Special Issue "Ion Channel Neurotoxins"
A special issue of Toxins (ISSN 2072-6651).
Deadline for manuscript submissions: closed (31 August 2014) | Viewed by 25686
Interests: antimicrobial peptides; antibacterial; antibiotics; structure-activity relationships; bacteriocins; drug design; peptide engineering
Special Issues, Collections and Topics in MDPI journals
Special Issue in Toxins: Toxins - Organic and Analytical Chemistry
Special Issue in Toxins: Animal Venoms
Special Issue in Molecules: Structure-Activity Relationship of Natural Products
Special Issue in Molecules: Natural Toxins/Molecules (and Derivatives) from Animal Venoms: From Basic Research to Therapeutic Applications
Special Issue in Marine Drugs: Ion Channels as Marine Drug Targets
Special Issue in Molecules: Natural Toxins/Molecules (and Derivatives) from Animal Venoms: from Basic Research to Therapeutic Applications 2019
Special Issue in Antibiotics: Antibacterial Peptides
Special Issue in Antibiotics: Peptide Antibiotics from Microbes and Venomous Animals
Special Issue in Marine Drugs: Ion Channels as Marine Drug Targets 2021
Special Issue in Sci: Natural Extracts and Bioactive Derivatives: Strategies for Biopharmaceutical Uses
Special Issue in Antibiotics: 10th Anniversary of Antibiotics–Recent Advances in Antimicrobial Peptides
Special Issue in Molecules: Medicinal Chemistry in Europe III
Special Issue in Molecules: Bioactive Molecules in SARS-CoV-2 Infection and Covid-19
Special Issue in Antibiotics: Reviews on Antimicrobial Peptides
Animal venoms (scorpions, snakes, cone snails, worms, sea anemones, frogs, wasps, etc.) are invaluable sources of pharmacologically-active compounds with various molecular targets. Among venom compounds, peptide toxins target the diverse ion channels (potassium, calcium, sodium and chloride channels). These molecules are often highly potent, more or less selective and, sometimes, have a potential therapeutic value depending on their cellular targets. Some peptide toxins are structurally optimized to be developed as candidate drugs to treat pain and specific human pathologies, such as autoimmune and neurological disorders. This special issue of ‘Toxins’ deals with all aspects of the venomous molecules, including structural properties, pharmacology, structure-activity relationships, toxin-based drug design, toxin engineering and development as chemotherapeutic drugs.
Dr. Jean-Marc Sabatier
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a double-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Toxins is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2400 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- animal toxin
- venomous animal
- ion channel
- ion channel modulator
- drug design
- toxin engineering
- chemotherapeutic drug